McInerney-Leo Aideen, Gwinn-Hardy Katrina, Nussbaum Robert L
Medical Genetics Branch, National Human Genome Research Institute, Building 10, Room 3C710, 10 Center Drive, MSC 1253, Bethesda, MD 20892-1253, USA.
J Natl Med Assoc. 2004 Jul;96(7):974-9.
There have been a number of studies looking at the prevalence of Parkinson's disease (PD) in different racial and geographical populations. Some of the earliest studies suggested a difference in the prevalence of PD in African Americans as compared with Caucasians. As such a difference would have important implications for healthcare and research into the etiology of PD, we undertook a review of published studies to determine whether evidence suggested that such a difference exists. We reviewed 20 studies that looked at incidence, prevalence, and percentages of neurology patients with PD and Parkinsonism in Africa and in African-American populations. Two of these were door-to-door studies that relied on questionnaires for initial ascertainment, another was performed by review of outpatient records of a large health maintenance organization, while the remainder were based on hospital admissions, diagnosis in the community, or death certificate reports. In the aggregate, these studies suggest PD may be less frequent among Africans and African Americans than among Caucasians, although the most well-designed study showed only a statistically insignificant reduction in the prevalence of PD among African Americans. Although an apparently lower disease frequency among people of African origin may have a basis in the pathobiology of the disease, nearly all of these studies were vulnerable to a variety of ascertainment biases, and many lacked stringent application of diagnostic criteria applied by specialists trained in movement disorders. We conclude that a difference in the prevalence of PD and Parkinsonism between black and other populations is unproven and will require additional well-designed studies to determine if previously reported ethnic differences in disease prevalence are real.
已有多项研究关注帕金森病(PD)在不同种族和地域人群中的患病率。一些早期研究表明,非裔美国人与白种人相比,PD患病率存在差异。鉴于这种差异对医疗保健和PD病因研究具有重要意义,我们对已发表的研究进行了综述,以确定是否有证据表明这种差异确实存在。我们回顾了20项研究,这些研究涉及非洲和非裔美国人群中PD和帕金森综合征的发病率、患病率以及神经科患者的百分比。其中两项是挨家挨户的研究,最初通过问卷调查进行确定;另一项是通过对一家大型健康维护组织的门诊记录进行审查完成的,其余的则基于医院入院情况、社区诊断或死亡证明报告。总体而言,这些研究表明,非洲人和非裔美国人中的PD可能比白种人更为少见,尽管设计最完善的研究仅显示非裔美国人中PD患病率的降低在统计学上无显著意义。虽然非洲裔人群中疾病频率明显较低可能在疾病的病理生物学方面有一定依据,但几乎所有这些研究都容易受到各种确定偏倚的影响,而且许多研究缺乏由运动障碍专科培训的专家严格应用诊断标准。我们得出结论,黑人和其他人群之间PD和帕金森综合征患病率的差异尚未得到证实,需要更多设计完善的研究来确定之前报道的疾病患病率的种族差异是否真实存在。